These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 477560)

  • 1. [Does low-dosage heparin treatment require serial haematological controls? (author's transl)].
    Bruhn HD; Albert JP; Sachs L; Timme H
    Dtsch Med Wochenschr; 1979 Sep; 104(38):1336-9. PubMed ID: 477560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin level and coagulation potential after subcutaneous injection of 7500 international units of heparin calcium].
    Briel RC
    Dtsch Med Wochenschr; 1984 Jun; 109(25):993-6. PubMed ID: 6734457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
    Gerhards H; Eberhardt C
    Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin and antiheparin in childhood. 3. Heparin level measurements and their importance in heparin monitoring].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):146-61. PubMed ID: 6192049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
    Kussmann J; Hirche H; Sengupta R
    Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Informative value of control methods for postoperative supervision of medication with aspirin and heparin (author's transl)].
    Schöndorf TH; Hey D
    MMW Munch Med Wochenschr; 1977 Jan; 119(4):119-22. PubMed ID: 402555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of low-dose-heparin and its control (author's transl)].
    Zanoni G
    Schweiz Rundsch Med Prax; 1976 Apr; 65(16):477-80. PubMed ID: 981166
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
    Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of postoperative thrombo-embolic accidents following thoracic surgery by low-dose calcium heparinate: a comparative study (author's transl)].
    Le Brigand H; Morille P; Garnier B; Bogaty-Yver J; Samama M; Spriet A
    Sem Hop; 1981 May 18-25; 57(19-20):972-7. PubMed ID: 6266028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY; Hawthorne WJ; Coombs R; Fletcher JP
    Int Angiol; 1999 Jun; 18(2):131-9. PubMed ID: 10424369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M; Fey MF; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for the monitoring of direct thrombin inhibitors.
    Hafner G; Roser M; Nauck M
    Semin Thromb Hemost; 2002 Oct; 28(5):425-30. PubMed ID: 12420237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary antithrombin III deficiency causing recurrent thrombo-embolic problems (author's transl)].
    Bessot JC; Quoix E; Charbonneau J; Burghard G; Wiesel ML; Kalogjera N; Mayer S; Mayer G
    Nouv Presse Med; 1978 Mar; 7(12):999-1002. PubMed ID: 662621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
    Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML
    Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.